(2S,3S,Z)-N'-(4-chlorobenzylidene)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanehydrazide

ID: ALA3580865

PubChem CID: 122178488

Max Phase: Preclinical

Molecular Formula: C21H20ClN3O3

Molecular Weight: 397.86

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@@H](C(=O)N/N=C\c1ccc(Cl)cc1)N1C(=O)c2ccccc2C1=O

Standard InChI:  InChI=1S/C21H20ClN3O3/c1-3-13(2)18(19(26)24-23-12-14-8-10-15(22)11-9-14)25-20(27)16-6-4-5-7-17(16)21(25)28/h4-13,18H,3H2,1-2H3,(H,24,26)/b23-12-/t13-,18-/m0/s1

Standard InChI Key:  XKDGALMVBDIMOF-MDQKUCICSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0872    0.0382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0825    2.3453    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0907   -2.3426    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8208    1.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2072    2.3788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8520   -1.2531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3215    1.3677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0552    2.6770    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5559    2.6972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3246    1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8245    1.4262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5901    0.1363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8558   -1.1717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3559   -1.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5903    0.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1168   -2.5616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7283   -3.5941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0519   -1.2394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4683   -2.2036    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  8 10  1  0
  9 11  2  0
  7 12  2  0
 10 13  1  6
 13 14  2  0
 10 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 15 25  1  0
 25 26  1  0
 15 27  1  1
 22 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3580865

    ---

Associated Targets(Human)

Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.86Molecular Weight (Monoisotopic): 397.1193AlogP: 3.50#Rotatable Bonds: 6
Polar Surface Area: 78.84Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.61CX Basic pKa: 1.31CX LogP: 4.23CX LogD: 4.23
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.46Np Likeness Score: -1.18

References

1. Coelho LCD, Cardoso MVdO, Moreira DRM, Gomes PATdM, Cavalcanti SMT, Oliveira AR, Filho GBdO, Siqueira LRPd, Barbosa MdO, Borba EFdO, Silva TGd, Kaskow B, Karimi M, Abraham LJ, Leite ACL.  (2014)  Novel phthalimide derivatives with TNF- and IL-1 expression inhibitory and apoptotic inducing properties,  (6): [10.1039/C4MD00070F]

Source